Specialists in pharmaceutical biotechnology from the US, Germany, South Africa, and Ireland introduce the concepts and technologies of the field, then examine industrial development and the production process, special pharmaceutical aspects of therapeutic proteins, and prospects for the industry into the next decade. Among their topics are procaryotic and eucaryotic cells, the development of DNA vaccines from research tools in mice to vaccines for humans, the pharmacokinetics and pharmacodynamics of biotech drugs, and nonviral gene transfer system in somatic gene therapy. They write not only for fellow scientists, but also for decision makers in pharmaceutical and biotechnological companies, in venture capital and finance, and in politics.
